Whilst CD151 expression modulation plays a critical role in determining disease progression, whether in promoting pathophysiology of lung cancer, asthma, and influenza or in potentially protecting against IPF, there is a distinct gap in the literature pertaining to the mechanisms underlying these changes. This evidence concerns the gene CD151 and lung cancer.